Hanna Ljung

Medicin och livsvetenskap

1. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 45%
2. Amyloid 36%
3. Anticonvulsants 60%
4. Arteries 9%
5. Carbamazepine 14%
6. Carotid Stenosis 14%
7. Case-Control Studies 30%
8. Cerebrovascular Circulation 12%
9. Child 11%
10. Clinical Trials 13%
11. Docosahexaenoic Acids 18%
12. Drug Resistant Epilepsy 43%
13. Economic Inflation 43%
14. Eicosapentaenoic Acid 18%
15. Elderly 25%
16. Epilepsy 36%
17. Executive Function 9%
18. Expert Testimony 13%
19. flutemetamol 47%
20. Generalized Epilepsy 17%
21. Heart Arrest 38%
22. Hippocampus 30%
23. Hypothermia 40%
24. Language 14%
25. Levetiracetam 51%
26. Licensure 13%
27. Magnetic Resonance Imaging 50%
28. Memory 62%
29. Memory and Learning Tests 39%
30. Mental Disorders 16%
31. Meta-Analysis 9%
32. Middle Cerebral Artery 13%
33. Myocardial Infarction 10%
34. Nervous System Diseases 14%
35. Omega-3 Fatty Acids 42%
36. Out-of-Hospital Cardiac Arrest 49%
37. Partial Epilepsy 45%
38. Pathology 26%
39. Patient Rights 41%
40. perampanel 64%
41. Pharmacology 17%
42. Positron-Emission Tomography 23%
43. Safety 23%
44. Sclerosis 19%
45. Seizures 34%
46. Temporal Lobe 39%
47. Temporal Lobe Epilepsy 100%
48. Therapeutics 11%
49. Topiramate 50%
50. Zonisamide 57%